The Critical Medicines Alliance (CMA) - a consultative mechanism bringing together relevant stakeholders from Member States, industry, civil society and the scientific community - has invited the European Commission to take into account its recommendations, published on Friday 28 February, when developing measures to strengthen the resilience of critical medicines supply chains.
In particular, the Alliance “looks forward to the legislation on critical medicines, which the Commission is...